Use of bone morphogenic protein (BMP) has risen sharply in the past decade, adding costs without evidence of better outcomes, according to a study in the February 2012 issue of Spine.
Welcome to OR Manager, your source of information and insight into the clinical and business management of the surgical suite. This article is only available to OR Manager subscribers. To read this article, and gain access to all OR Manager resources, please log in below:
Username
Password
Explore Subscription Options
Please contact our Customer Service Team if you are unable to log in at clientservices@accessintel.com or 1-888-707-5814.
Effective communication is the foundation of patient safety in the…
Find out more
Takeaways • US surgeons have no mandated retirement age. According…
The poster presentations at the 2024 OR Manager Conference showcased…
